You did everything right. You fought for the labs and pushed past the doctor who said your TSH was “fine.” The prescription came — levothyroxine, maybe Synthroid — taken on an empty stomach, thirty minutes before coffee, every morning for months.
And you’re still exhausted: hair still thinning, brain still stalling mid-sentence, body running on dial-up. The labs improved. You didn’t.
Your medication is doing exactly what it was designed to do: replace a hormone. The problem is that hormone replacement was never the whole story; the rest of that story lives in a single enzymatic step most doctors never check.
The Conversion Problem
Your thyroid gland makes mostly T4 — a storage hormone, a precursor. Your body has to convert that T4 into T3, the active form that actually drives metabolism, energy, and cognitive function. Levothyroxine is synthetic T4, which gives your body more raw material to work with.
What it doesn’t do: fix why your body isn’t converting T4 to T3.
T4-to-T3 conversion depends on terrain — the underlying physiological conditions your thyroid operates inside. When terrain is compromised, your body shunts T4 into reverse T3 (rT3) instead of active T3. Reverse T3 is the brake your peripheral tissues apply when the system cannot afford full throttle, a deiodinase-level decision rather than a thyroid one. The prescription filled the tank. The engine can’t burn the fuel.
You can have a “normal” TSH, adequate T4 levels, and still be functionally hypothyroid at the cellular level.
Where Conversion Breaks Down
The terrain culprits are specific and measurable:
Chronic stress physiology. Sustained HPA activation drives cortisol output that suppresses the deiodinase enzymes responsible for T4-to-T3 conversion. Your body reads prolonged stress as a signal to conserve energy, and it does — by throttling metabolism at the conversion step. More medication doesn’t override this signal. It gives you more T4 to shunt into rT3.
Systemic inflammation. Inflammatory cytokines directly block T4-to-T3 conversion. If you have gut dysbiosis, insulin resistance, chronic infections, or unresolved immune activation, these conditions compromise your conversion pathway before the levothyroxine even hits the bloodstream.
Insulin resistance. Insulin resistance suppresses T4-to-T3 conversion through both direct mechanisms and the inflammatory burden it carries, which means it can compound the problem even when inflammation isn’t the primary driver. The woman who cleaned up her diet, added strength training, and is still watching the scale move the wrong direction is often carrying insulin resistance that’s been compounding the conversion problem the entire time, before anyone thought to check it.
Gut absorption. The small intestine absorbs levothyroxine. Celiac disease and chronic PPI use are among the better-documented culprits, but any condition disrupting small intestinal function can reduce how much levothyroxine actually reaches the bloodstream, and the losses can be substantial. You may be absorbing a fraction of your prescribed dose and compensating by running harder on a system that’s already depleted.
None of these variables appear on a standard thyroid panel, which explains exactly what happens when you report that the medication isn’t working.
Why Your Doctor Keeps Adjusting the Dose
When you report that you’re still symptomatic, the standard response is: increase the dose, or switch to a different formulation. Sometimes that helps briefly — until the fatigue creeps back, new symptoms appear (anxiety, palpitations, insomnia), and you’re caught between too much and not enough.
Titrating a hormone without addressing the terrain it operates inside produces a predictable pattern: the dose gets adjusted, the symptoms shift, the window closes. Conversion capacity is the variable that matters most; it’s downstream of your nervous system state, your inflammatory load, your metabolic flexibility, and your gut integrity.
Dose adjustment isn’t wrong: sometimes more T4 is exactly what’s needed. But when conversion is impaired, you’re optimizing one variable while the actual bottleneck sits upstream; that bottleneck has a clinical signature worth reading.
What the Signal Means
High rT3 with normal or low FT3 is survive-first signaling. Your body is saying: the load exceeds what I can safely sustain at full metabolic output. A body conserving metabolic output under genuine threat is doing its job: the down-regulation is the intelligence. More hormone doesn’t change that calculus.
Changing the calculus requires addressing the nervous system load before optimizing the thyroid protocol: stabilizing blood sugar so insulin stops sabotaging conversion, reducing the inflammatory burden so deiodinase enzymes can do their job, restoring gut function so the medication you’re already taking can actually absorb.
One legitimate response to impaired conversion is bypassing it entirely: desiccated thyroid (Armour) and synthetic T3 (cytomel) deliver active T3 directly, sidestepping the conversion step that’s failing. Whether that’s appropriate depends on your full picture, but it belongs in the conversation, especially when you’ve optimized T4 monotherapy and you’re still symptomatic.
The prescription addressed the gland. It never had instructions for the ground it sits on.
The Question Worth Asking
What does your terrain need before this dose can work?
If you’ve been on thyroid medication for months and your body still isn’t converting T4 to T3 efficiently, your terrain is telling you something the prescription can’t fix.
If this sounds like you — you’ve done the protocols, adjusted the dose, and your body still isn’t cooperating — book a Vital Signal Check. Forty-five minutes to decode what your body is actually signaling, and why the medication isn’t landing.